Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Fundy13on Nov 05, 2018 2:53pm
129 Views
Post# 28925995

RE:RE:RE:RE:RE:Uhhhh!!

RE:RE:RE:RE:RE:Uhhhh!!You would be amazed at how many people buy stocks without know how many shares are outstanding and the companies market cap.  They see Company A trading at $2.00 jper share and say I think Company B is worth more than Compnay A so it should trade at more then $2.00 per share.
They do not even know that Company B has 10 times more shares outstanding and is already trading at a higher value than Company A even though the share price is lower..  The company is worth about $650million dollars right now, in the same range as Auxley, the companythat financed the build and that owns 50% of all the product grow and has stakes in about 25 other companies on top of their ownership in HUGE. Organigram also has a similar Market Cap, a much more devoloped business that has gov't contracts to supply Cannibas stores.
I like HUGE as a long term play, but they are certainly not undervalued right now at the stage they are at.
Bullboard Posts